TerrAscend Corp. (CNSX:TER) signed a definitive agreement to acquire HMS Health, LLC and HMS Processing, LLC from Curaleaf Holdings, Inc. (CNSX:CURA) for $27.5 million on November 6, 2020. The consideration is comprised of $25 million in cash and a $2.5 million note which bears 5.0% annual interest, due April 2022. With the acquisition TerrAscend will leverage their strong management team and corporate support functions to drive economies of scale. Upon closing, 100% of HMS' economics will be retained by TerrAscend through full ownership of HMS Health, LLC and a master services agreement with HMS Processing, LLC. The acquisition is subject to certain closing conditions, including approvals from regulatory authorities. The closing of the transaction is expected to occur in the first quarter of 2021. The transfer of 100% equity of HMS processing is expected to close in April 2022. The acquisition is expected to be immediately accretive to TerrAscend on an EBITDA basis.

TerrAscend Corp. (CNSX:TER) completed the acquisition of HMS Health, LLC and HMS Processing, LLC from Curaleaf Holdings, Inc. (CNSX:CURA) on May 4, 2021.